| DB ID | MyCo_1751 |
| Title | Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis |
| Year | 2019 |
| PMID | 31484389 |
| Fungal Diseases involved | Invasive aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | All procedures were supervised and approved by the Universitat Rovira i Virgili Animal Welfare and Ethics Committee (URV reference 0247, 15 March 2017). |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Animal |
| Host Common name | Mice |
| Host Scientific name | Mus musculus |
| Biomarker Name | VEGF |
| Biomarker Full Name | Vascular endothelial growth factor |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Multi-Location |
| Cohort | A total of 75 OF-1 four-week-old male mice weighing 35 g (Charles River, Criffa S.A. Barcelona, Spain) were divided into groups of 15 animals/group, with 10 used for the survival studies and 5 for fungal load determination. |
| Cohort No. | 75 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ELISA |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
